Chain Drug Review - Lilly Ups Support for Evista
Wednesday, January 7th, 2009 INDIANAPOLIS — Eli Lilly and Co. is providing additional support for Evista, its osteoporosis preventive, by reorganizing its pharmaceutical sales force.
Evista, known generically as raloxifene hydrochloride, is marketed for the prevention of osteoporosis in postmenopausal women.
…
